{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:27:56Z","timestamp":1793399276432,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"FOREUM Foundation for Research in Rheumatology"},{"name":"The UK JIA Biologic Registers\u2014including the Biologics for Children with Rheumatic Diseases"},{"name":"BSPAR Etanercept Cohort (BSPAR-ETN) study\u2014are jointly funded by the British Society for Rheumatology"},{"name":"Arthritis (UK","award":["20747"],"award-info":[{"award-number":["20747"]}]},{"name":"University of Manchester are additionally supported by the Centre for Epidemiology","award":["21755"],"award-info":[{"award-number":["21755"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Burden of comorbidities are largely unknown in JIA. From 2000, national and international patient registries were established to monitor biologic treatment, disease activity and adverse events in patients with JIA. The aim of this analysis was to investigate in parallel, for the first time, three of the largest JIA registries in Europe\/internationally\u2014UK JIA Biologic Registers (BCRD\/BSPAR-ETN), German biologic registers (BiKeR\/JuMBO), multinational Pharmachild\u2014to quantify the occurrence of selected comorbidities in patients with JIA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Information on which data the registers collect were compared. Patient characteristics and levels of comorbidity were presented, focussing on four key conditions: uveitis, MAS, varicella, and history of tuberculosis. Incidence rates of these on MTX\/biologic therapy were determined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>8066 patients were registered into the three JIA registers with similar history of the four comorbidities across the studies; however, varicella vaccination coverage was higher in Germany (56%) vs UK\/Pharmachild (16%\/13%). At final follow-up, prevalence of varicella infection was lower in Germany (15%) vs UK\/Pharmachild (37%\/50%). Prevalence of TB (0.1\u20131.8%) and uveitis (15\u201319%) was similar across all registers. The proportion of systemic-JIA patients who ever had MAS was lower in Germany (6%) vs UK (15%) and Pharmachild (17%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This analysis is the first and largest to investigate the occurrence of four important comorbidities in three JIA registries in Europe and the role of anti-rheumatic drugs. Combined, these three registries represent one of the biggest collection of cases of JIA worldwide and offer a unique setting for future JIA outcome studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab641","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T19:17:17Z","timestamp":1632251837000},"page":"2524-2534","source":"Crossref","is-referenced-by-count":23,"title":["Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0377-1575","authenticated-orcid":false,"given":"Lianne","family":"Kearsley-Fleet","sequence":"first","affiliation":[{"name":"Centre for Epidemiology Versus Arthritis, Manchester Academic Health Science Centre, The University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Klotsche","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, German Rheumatism Research Centre , Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8766-6694","authenticated-orcid":false,"given":"Joeri W","family":"van Straalen","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Rheumatology, Wilhelmina Children\u2019s Hospital, University Medical Center , Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Costello","sequence":"additional","affiliation":[{"name":"iIrish Children\u2019s Arthritis Network (iCAN), Bansha, Co Tipperary, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"D\u2019Angelo","sequence":"additional","affiliation":[{"name":"Paediatrics, Ospedale Pediatrico G. Salesi di Ancona , Ancona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Giancane","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini , Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Asklepios Kinderklinik Sankt Augustin , Sankt Augustin"},{"name":"Department of Pediatric and Adolescent Medicine, Medical Faculty, University Hospital of Cologne , Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Asklepios Kinderklinik Sankt Augustin , Sankt Augustin"},{"name":"Department of Pediatric and Adolescent Medicine, Medical Faculty, University Hospital of Cologne , Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"L\u00e1day","sequence":"additional","affiliation":[{"name":"Pediatric Clinical Department 1, Spitalul Clinic Judetean De Urgenta , T\u00eergu-Mure\u0219, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lunt","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology Versus Arthritis, Manchester Academic Health Science Centre, The University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sytze","family":"de Roock","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Rheumatology, Wilhelmina Children\u2019s Hospital, University Medical Center , Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8407-7782","authenticated-orcid":false,"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini , Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"Schoemaker","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Rheumatology, Wilhelmina Children\u2019s Hospital, University Medical Center , Utrecht, Netherlands"},{"name":"Dutch JIA Patient and Parent Organisation (Member of ENCA) , Rijen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Vijatov-Djuric","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Novi Sad"},{"name":"Department of Immunology, Allergology and Rheumatology, Institute for Child and Youth Health Care of Vojvodina , Novi Sad"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Vojinovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Pediatric Immunology and Rheumatology, University of Nis, University Clinic Center"},{"name":"Department of Pediatric Rheumatology, Clinical Center Nis, Clinic of Pediatrics , Nis, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vougiouka","sequence":"additional","affiliation":[{"name":"\u2018P a A Kyriakou\u2019 Children\u2019s Hospital, 2nd Paediatric Department, Athens University School of Medicine , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M","family":"Wulffraat","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Rheumatology, Wilhelmina Children\u2019s Hospital, University Medical Center , Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"UK JIA Biologics Registers Investigators Group; Paediatric Rheumatology International Trials Organisation (PRINTO)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-9262","authenticated-orcid":false,"given":"Kimme L","family":"Hyrich","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology Versus Arthritis, Manchester Academic Health Science Centre, The University of Manchester , Manchester, UK"},{"name":"NIHR Manchester BRC, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Minden","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, German Rheumatism Research Centre , Berlin, Germany"},{"name":"Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health , Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-2822","authenticated-orcid":false,"given":"Joost F","family":"Swart","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Rheumatology, Wilhelmina Children\u2019s Hospital, University Medical Center , Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"2022060107535515700_keab641-B1","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"2022060107535515700_keab641-B2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"2022060107535515700_keab641-B3","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2022060107535515700_keab641-B4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12891-016-1129-1","article-title":"Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom","volume":"17","author":"Angelis","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2022060107535515700_keab641-B5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/CLEP.S45305","article-title":"Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs","volume":"5","author":"Ording","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2022060107535515700_keab641-B6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","article-title":"Juvenile idiopathic arthritis\u2013associated uveitis","volume":"14","author":"Clarke","year":"2016","journal-title":"Pediatr Rheumatol"},{"key":"2022060107535515700_keab641-B7","first-page":"4322","article-title":"Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis","volume":"21","author":"An","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2022060107535515700_keab641-B8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-018-1780-z","article-title":"Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries","volume":"20","author":"Swart","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2022060107535515700_keab641-B9","first-page":"189","year":"2019"},{"key":"2022060107535515700_keab641-B10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1370\/afm.983","article-title":"Defining comorbidity: implications for understanding health and health services","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann Fam Med"},{"key":"2022060107535515700_keab641-B11","first-page":"154","article-title":"Comorbidities in rheumatoid arthritis: analysis of hospital discharge records","volume":"57","author":"Parodi","year":"2005","journal-title":"Reumatismo"},{"key":"2022060107535515700_keab641-B12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/rheumatology\/kev429","article-title":"Factors associated with choice of biologic among children with juvenile idiopathic arthritis: results from two UK paediatric biologic registers","volume":"55","author":"Kearsley-Fleet","year":"2016","journal-title":"Rheumatology"},{"key":"2022060107535515700_keab641-B13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.1780371209","article-title":"Measurement of health status in children with juvenile rheumatoid arthritis","volume":"37","author":"Singh","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2022060107535515700_keab641-B14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/adc.2010.188946","article-title":"Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO)","volume":"96","author":"Ruperto","year":"2011","journal-title":"Arch Dis Child"},{"key":"2022060107535515700_keab641-B15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3899\/jrheum.100930","article-title":"A new approach to clinical care of juvenile idiopathic arthritis: the juvenile arthritis multidimensional assessment report","volume":"38","author":"Filocamo","year":"2011","journal-title":"J Rheumatol"},{"key":"2022060107535515700_keab641-B16","year":"2019"},{"key":"2022060107535515700_keab641-B17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-020-02167-2","article-title":"Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee","volume":"22","author":"Giancane","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022060107535515700_keab641-B18","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/cid\/ciz1138","article-title":"Tuberculosis disease in children and adolescents on therapy with antitumor necrosis factor-\u0251 agents: a collaborative, multicenter Paediatric Tuberculosis Network European Trials Group (PTBNET) study","volume":"71","author":"Noguera-Julian","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022060107535515700_keab641-B19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/key207","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis\u2014executive summary","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatology"},{"key":"2022060107535515700_keab641-B20","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.38092","article-title":"2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications","volume":"65","author":"Ringold","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022060107535515700_keab641-B21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","article-title":"Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines","volume":"46","author":"Heiligenhaus","year":"2007","journal-title":"Rheumatology"},{"key":"2022060107535515700_keab641-B22","first-page":"147","year":"2019"},{"key":"2022060107535515700_keab641-B23","author":"Nash","year":"2020"},{"key":"2022060107535515700_keab641-B24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2022060107535515700_keab641-B25","first-page":"213","article-title":"Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs","volume":"68","author":"Gabutti","year":"2016","journal-title":"Minerva Pediatr"},{"key":"2022060107535515700_keab641-B26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpeds.2018.08.065","article-title":"Risk of serious infections associated with biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analyses","volume":"204","author":"Aeschlimann","year":"2019","journal-title":"J Pediatr"},{"key":"2022060107535515700_keab641-B27","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2015.06.086","article-title":"Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy","volume":"33","author":"Toplak","year":"2015","journal-title":"Vaccine"},{"key":"2022060107535515700_keab641-B28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022060107535515700_keab641-B29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","article-title":"Varicella vaccination in Europe \u2013 taking the practical approach","volume":"7","author":"Bonanni","year":"2009","journal-title":"BMC Med"},{"key":"2022060107535515700_keab641-B30","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2015.03.055","article-title":"Varicella in Europe\u2014a review of the epidemiology and experience with vaccination","volume":"33","author":"Helmuth","year":"2015","journal-title":"Vaccine"},{"key":"2022060107535515700_keab641-B31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/hpeds.2017-0086","article-title":"Study of complications of Varicella-Zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment","volume":"8","author":"Diniz","year":"2018","journal-title":"Hosp Pediatr"},{"key":"2022060107535515700_keab641-B32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"2022060107535515700_keab641-B33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2022060107535515700_keab641-B34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2022060107535515700_keab641-B35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12703\/P6-21","article-title":"Treatment advances in systemic juvenile idiopathic arthritis","volume":"6","author":"Beukelman","year":"2014","journal-title":"F1000Prime Rep"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab641\/40545079\/keab641.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/6\/2524\/43891522\/keab641.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/6\/2524\/43891522\/keab641.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:54:54Z","timestamp":1654070094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/6\/2524\/6382321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,10,6]]},"published-print":{"date-parts":[[2022,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab641","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2021,10,6]]}}}